These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29581372)

  • 21. Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment-Elevation Myocardial Infarction: The MIMI Study.
    Belle L; Motreff P; Mangin L; Rangé G; Marcaggi X; Marie A; Ferrier N; Dubreuil O; Zemour G; Souteyrand G; Caussin C; Amabile N; Isaaz K; Dauphin R; Koning R; Robin C; Faurie B; Bonello L; Champin S; Delhaye C; Cuilleret F; Mewton N; Genty C; Viallon M; Bosson JL; Croisille P;
    Circ Cardiovasc Interv; 2016 Mar; 9(3):e003388. PubMed ID: 26957418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Nepper-Christensen L; Lønborg J; Ahtarovski KA; Høfsten DE; Kyhl K; Ghotbi AA; Schoos MM; Göransson C; Bertelsen L; Køber L; Helqvist S; Pedersen F; Saünamaki K; Jørgensen E; Kelbæk H; Holmvang L; Vejlstrup N; Engstrøm T
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28069574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; de Prado AP; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2014 Jul; 130(3):e19-20. PubMed ID: 25024129
    [No Abstract]   [Full Text] [Related]  

  • 24. Factors associated with delay in transfer of patients with ST-segment elevation myocardial infarction from first medical contact to catheterization laboratory: Lessons from CRAC, a French prospective multicentre registry.
    Rangé G; Saint Etienne C; Marcollet P; Chassaing S; Dequenne P; Hakim R; Capsec J; Laure C; Gautier S; Albert F; Godillon L; Stolt P; Motreff P; Grammatico-Guillon L
    Arch Cardiovasc Dis; 2019 Jan; 112(1):3-11. PubMed ID: 30655225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter by Argulian and Messerli regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial".
    Argulian E; Messerli FH
    Circulation; 2014 Jul; 130(3):e18. PubMed ID: 25024128
    [No Abstract]   [Full Text] [Related]  

  • 26. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials.
    Taglieri N; Bacchi Reggiani ML; Ghetti G; Saia F; Compagnone M; Lanati G; Di Dio MT; Bruno A; Bruno M; Della Riva D; Corsini A; Narducci R; Rapezzi C
    Eur Heart J Acute Cardiovasc Care; 2019 Feb; 8(1):24-38. PubMed ID: 30160519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Relative Conditional Survival Estimates on Patient Prognosis After Percutaneous Coronary Intervention.
    Baart SJ; van Domburg RT; Janssen-Heijnen MLG; Deckers JW; Akkerhuis KM; Daemen J; van Geuns RJ; Boersma E; Kardys I
    Circ Cardiovasc Qual Outcomes; 2017 Jun; 10(6):. PubMed ID: 28619724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study).
    Ko YG; Won H; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Bae JH; Lee S; Lim DS; Jang Y
    Am J Cardiol; 2014 Jul; 114(1):29-35. PubMed ID: 24831577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination Therapy to Target Reperfusion Injury After ST-Segment-Elevation Myocardial Infarction: A More Effective Approach to Cardioprotection.
    Hausenloy DJ; Yellon DM
    Circulation; 2017 Sep; 136(10):904-906. PubMed ID: 28874421
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of a combination of antiplatelet and antithrombotic pretreatment on myocardial perfusion in patients with an acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Prech M; Bartela E; Janus M; Jeremicz I; Araszkiewicz A; Urbanska L; Pyda M; Grajek S
    Coron Artery Dis; 2016 Nov; 27(7):580-5. PubMed ID: 27228184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
    Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Kuijt WJ; Green CL; Verouden NJW; Haeck JDE; Tzivoni D; Koch KT; Stone GW; Lansky AJ; Broderick S; Tijssen JGP; de Winter RJ; Roe MT; Krucoff MW
    J Electrocardiol; 2017; 50(6):952-959. PubMed ID: 29153151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of QRS fragmentation and correlation with infarct size in patients with anterior ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: Insights from the INFUSE-AMI trial.
    Redfors B; Kosmidou I; Crowley A; Maehara A; Ben-Yehuda O; Arif A; Dizon JM; Mintz GS; Stone GW
    Int J Cardiol; 2018 Feb; 253():20-24. PubMed ID: 29306465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
    Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
    Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.